Registry for patients with pancreatic ductal adenocarcinoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

PaCaReg is a multicenter registry that collects data on the clinical, epidemiological, and biological characteristics of patients diagnosed with pancreatic ductal adenocarcinoma. The study aims to gather comprehensive information to better understand the disease and improve future treatment strategies. Participants must be treatment-naive and provide written informed consent to be included in the registry. The study focuses on patients with confirmed or highly suspicious diagnoses of pancreatic cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
* Age =\>18 years
* written informed consent

Exclusion Criteria:

* papillary cancer
* neuroendocrine pancreatic tumors

Where it's running

• Universitätsklinikum Ulm
  Ulm, Germany Recruiting

Study contacts

• Principal investigator: Thomas Seufferlein, MD — Ulm University Hospital
• Study coordinator: Thomas Seufferlein, MD
• Email: thomas.seufferlein@uniklinik-ulm.de
• Phone: +49 731 50044501

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Liquid biopsy biomarkers to detect and monitor pancreatic cancer

  Researchers test blood-based microRNA signals to see if they can identify pancreatic cancer risk or early disease in people with familial or hereditary risk or mucinous cysts.

  Recruiting Università Vita-Salute San Raffaele · Milan, MI · NCT07700992

• Neoadjuvant chemotherapy versus immediate surgery for resectable pancreatic head and periampullary cancer

  This trial tests if giving chemotherapy before surgery helps people with resectable pancreatic head or periampullary cancer live longer than having immediate surgery followed by chemotherapy.

  Recruiting Phase 3 Minia University · Minya, Minya Governorate · NCT07081360

• Predicting pancreatic fistula after pancreaticoduodenectomy

  This project will try to find which before-, during-, and after-surgery factors predict clinically significant pancreatic fistula in adults having pancreaticoduodenectomy for pancreatic or periampullary tumors.

  Recruiting Minia University · Minya · NCT07022015

• Surgery for pancreatic cancer with liver metastases after chemotherapy

  This study is testing whether surgery after chemotherapy can help people with pancreatic cancer that has spread to the liver live longer and have better outcomes.

  Recruiting Laval University · Québec, Quebec · NCT06349278

• Investigating lymph node metastasis in pancreatic cancer surgery

  This study is testing whether removing certain lymph nodes during pancreatic cancer surgery can help doctors understand how the cancer spreads and improve treatment for patients.

  Recruiting at 2 sites Uppsala University Hospital · Odense and 5 other locations · NCT06065891

• Assessing survival and quality of life in patients with advanced pancreatic cancer

  This study looks at how long people with advanced pancreatic cancer live and how their quality of life is affected while being treated at different hospitals in the Nordic region.

  Recruiting Umeå University · Umeå · NCT05356039

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.